SCHEMBL18459339

SCHEMBL18459339

CC(NC(=O)OCc1ccccc1)c1ccc(OCC2CN(C(=O)OC(C)(C)C)C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ YAP1 P46937 3/20 0.48
▸ P2RX7 Q99572 8/20 0.46
▸ BACE1 P56817 2/20 0.46
▸ CTSS P25774 2/20 0.46
▸ CTSK P43235 2/20 0.46
▸ CYP3A4 P08684 1/20 0.45
▸ TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18459337 1.00 YAP1 (0.48) YAP1P2RX7BACE1CTSSCTSK
SCHEMBL15075586 0.87 ACACB (0.49) YAP1P2RX7BACE1CYP3A4TSHR
SCHEMBL15048243 0.87 ACACB (0.49) YAP1P2RX7BACE1CYP3A4TSHR
SCHEMBL15083952 0.85 CCR1 (0.48) P2RX7BACE1CTSSCTSKCYP3A4
SCHEMBL16214228 0.82 ACACB (0.54) YAP1P2RX7BACE1CTSSCTSK
SCHEMBL20101866 0.81 CTSS (0.46) CTSSCTSKCYP3A4TSHR
SCHEMBL21248948 0.79 SYK (0.49) YAP1P2RX7BACE1
SCHEMBL796329 0.79 NAMPT (0.54) —
SCHEMBL31604809 0.78 YAP1 (0.49) YAP1P2RX7CTSSCTSK
SCHEMBL31604808 0.77 PPARA (0.46) YAP1P2RX7CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107849059-B 7-phenylethylamino-4H-pyrimido [4,5-D ] [1,3] oxazin-2-one compounds and their use as inhibitors of mutant IDH1 伊莱利利公司 2020-04-28 — — CN disclosed
EP-3328866-B1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS LILLY CO ELI (US) 2019-10-30 — — EP disclosed
WO-2017019429-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS ELI LILLY AND COMPANY (US) 2017-02-02 — — WO disclosed
Send feedback